Statements (27)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:Company
|
| gptkbp:acquisition |
gptkb:Teladoc_Health
$18.5 billion |
| gptkbp:acquisition_year |
October 2020
|
| gptkbp:ceo |
gptkb:Zeev_Neuwirth
|
| gptkbp:focus |
chronic condition management
|
| gptkbp:founded |
gptkb:2017
|
| gptkbp:founder |
M. Scott Kahn
|
| gptkbp:headquarters |
gptkb:San_Francisco,_California
|
| https://www.w3.org/2000/01/rdf-schema#label |
LVGO
|
| gptkbp:industry |
gptkb:health_services
|
| gptkbp:investment |
gptkb:Kleiner_Perkins
gptkb:Bessemer_Venture_Partners gptkb:General_Catalyst |
| gptkbp:mission |
empower people to live better lives.
|
| gptkbp:number_of_employees |
over 1,000
|
| gptkbp:partnership |
healthcare providers
|
| gptkbp:product |
gptkb:Livongo_for_Behavioral_Health
gptkb:Livongo_for_Diabetes gptkb:Livongo_for_Hypertension |
| gptkbp:revenue |
$100 million (2020)
|
| gptkbp:services |
digital health solutions
|
| gptkbp:stock_symbol |
gptkb:LVGO
|
| gptkbp:target_market |
people with diabetes
|
| gptkbp:website |
www.livongo.com
|
| gptkbp:bfsParent |
gptkb:LIVONGO
|
| gptkbp:bfsLayer |
5
|